OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive perspective of Huntington’s disease and mitochondrial dysfunction
Yinghong Dai, Haonan Wang, Aojie Lian, et al.
Mitochondrion (2023) Vol. 70, pp. 8-19
Open Access | Times Cited: 16

Showing 16 citing articles:

Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease
Alaa Shafie, Amal Adnan Ashour, Saleha Anwar, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 6, pp. 571-595
Closed Access | Times Cited: 9

Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease
Marta Pengo, Ferdinando Squitieri
Genes (2024) Vol. 15, Iss. 6, pp. 807-807
Open Access | Times Cited: 6

Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Asif Ahmad Bhat, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 6

Disruption of the mitochondrial network in a mouse model of Huntington's disease visualized by in-tissue multiscale 3D electron microscopy
Eva Martin-Solana, Laura Casado-Zueras, Teobaldo E. Torres, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4

Neurodegenerative disorders, metabolic icebergs, and mitohormesis
Matthew Phillips, Martin Picard
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4

Neurodegenerative diseases and neuroinflammation-induced apoptosis
Shi Huang, Yaxin Lu, Wenjun Fang, et al.
Open Life Sciences (2025) Vol. 20, Iss. 1
Open Access

Humanized rodent models of neurodegenerative diseases and other brain disorders
X.B Zhang, Jianxiang Wang, Jiewen Zhang, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106112-106112
Closed Access

Targeting LKB1–AMPK–SIRT1–induced autophagy and mitophagy pathways improves cerebrovascular homeostasis in APP/PS1 mice
Yawen Li, Tongxing Wang, Hong-Rong Li, et al.
Free Radical Biology and Medicine (2025)
Closed Access

Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets
Ayesha Nisar, Sawar Khan, Wen Li, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 3

CircHTT(2,3,4,5,6) — co-evolving with the HTT CAG-repeat tract — modulates Huntington's disease phenotypes
Jasmin Morandell, Alan Monziani, Martina Lazioli, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102234-102234
Open Access | Times Cited: 2

Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo 1H-MRS studies
Yinghua Jing, Imis Dogan, Kathrin Reetz, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106574-106574
Open Access | Times Cited: 1

Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington’s disease in the mouse model
Ying-Sui Lu, Wei-Chien Hung, Yu‐Ting Hsieh, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 413-429
Open Access | Times Cited: 1

Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington’s disease
Behnaz Nateghi, Rémi Keraudren, Gabriel Boulay, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1

Exploring melatonin’s therapeutic potential in neurological disorders: a review of current evidence
Mahaveer Singh, Saurabh Maru, Sinoy Sugunan, et al.
Biological Rhythm Research (2024), pp. 1-17
Closed Access

Page 1

Scroll to top